000			02018 a2200529 4500
005			20250515075947.0
264		0	_c20070920
008			200709s 0 0 eng d
022			_a1465-993X
024	7		_a10.1186/1465-9921-8-57 _2doi
040			_aNLM _beng _cNLM
100	1		_aBaumann, Ulrich
245	0	0	_aAssessment of pulmonary antibodies with induced sputum and bronchoalveolar lavage induced by nasal vaccination against Pseudomonas aeruginosa: a clinical phase I/II study. _h[electronic resource]
260			_bRespiratory research _cAug 2007
300			_a57 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Comparative Study; Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdministration, Intranasal
650	0	4	_aAdult
650	0	4	_aAntibodies, Bacterial _xblood
650	0	4	_aBacterial Proteins _xgenetics
650	0	4	_aBacterial Vaccines _xadministration & dosage
650	0	4	_aBronchoalveolar Lavage Fluid _ximmunology
650	0	4	_aFeasibility Studies
650	0	4	_aGels
650	0	4	_aHumans
650	0	4	_aImmunity, Mucosal
650	0	4	_aImmunization Schedule
650	0	4	_aImmunization, Secondary
650	0	4	_aImmunoglobulin A _xmetabolism
650	0	4	_aImmunoglobulin G _xmetabolism
650	0	4	_aInjections, Intramuscular
650	0	4	_aLipoproteins _xgenetics
650	0	4	_aPseudomonas Infections _ximmunology
650	0	4	_aPseudomonas aeruginosa _ximmunology
650	0	4	_aRecombinant Fusion Proteins _ximmunology
650	0	4	_aReference Values
650	0	4	_aRespiratory Mucosa _ximmunology
650	0	4	_aSputum _ximmunology
650	0	4	_aTime Factors
650	0	4	_aVaccination _xmethods
700	1		_aGöcke, Kerstin
700	1		_aGewecke, Britta
700	1		_aFreihorst, Joachim
700	1		_avon Specht, Bernd Ulrich
773	0		_tRespiratory research _gvol. 8 _gp. 57
856	4	0	_uhttps://doi.org/10.1186/1465-9921-8-57 _zAvailable from publisher's website
999			_c17215672 _d17215672